Neurogene NGNE
NASDAQ NGNE
$25.65 -0.90 (-3.39%)
At close: Oct 2, 2026 · 4:00 PM EDT

Neurogene (NGNE) Other Accumulated Expenses (2013 - 2022)

Updated

Neurogene's Other Accumulated Expenses was $1.17 million in Q4 2022, down 4.6% from $1.23 million a year earlier.

Analysis

Neurogene (NGNE) Other Accumulated Expenses (2013 - 2022) Analysis & Trends

From Q4 2013 onward, Neurogene has reported Other Accumulated Expenses for 9 quarters.

  • Other Accumulated Expenses shows a four-year compound annual growth rate of 48.6% (FY2018 to FY2022).
  • In earlier years, Other Accumulated Expenses was $1.23 million in FY2021 (+32.4%), $927,000 in FY2020 (+173.5%), $339,000 in FY2019 (+41.3%) and $240,000 in FY2018.
  • The Q4 2022 figure marks the lowest quarterly Other Accumulated Expenses since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Neurogene 578.46 Mn 578.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.17 Mn
Dec 31, 2021 1.23 Mn
Dec 31, 2020 927,000.00
Dec 31, 2019 339,000.00
Dec 31, 2018 240,000.00
Dec 31, 2014 3.75 Mn
Jun 30, 2014 19,727.00
Mar 31, 2014 16,907.00
Dec 31, 2013 565,170.00
API Access

Neurogene Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NGNE&period=max&api_key=YOUR_API_KEY